Shocks as predictors of survival in patients with implantable cardioverter-defibrillators

Journal of the American College of Cardiology

Volumn 34, Issue 1, 1999, Pages 204-210

  Pacifico, Antonio ^a   Ferlic, Laura L ^a,b   Cedillo Salazar, Félix E R ^a,b   Nasir Jr , Nadim ^a,b   Doyle, Timothy K ^a,b   Henry, Philip D ^a,b  

^a Texas Arrhythmia Institute   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROCONVULSIVE THERAPY; FEMALE; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

AGED; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0033165685     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00142-4     Document Type: Article

References (22)

1. Furman S. AICD benefit. Pacing Clin Electrophysiol. 12:1989;399-400.
2. Zilo P., Gross H.N., Benedek Z.M., Fisher J.D., Furman S. Occurrence of ICD shocks and patient survival. Pacing Clin Electrophysiol. 14:1991;273-279.
3. Tehou P., Axtell K., Keim S., et al. Does reception of appropriate shocks from the implantable cardioverter defibrillator affect survival? Pacing Clin Electrophysiol. 14:1991;1929-1934.
4. Levine J.H., Mellits E.D., Baumgardner R.A., et al. Predictors of first discharge and subsequent survival in patients with implantable cardioverter-defibrillators. Circulation. 94:1991;558-566.
5. Fogoros R.N., Elson J.J., Bonnet C.A. Survival of patients who have received appropriate shocks from their implantable defibrillators. Pacing Clin Electrophysiol. 14:1991;1842-1845.
6. Bilitch Registry Group , Gross J.N., Song S.L., Buckigham T., Furman S. Influence of clinical characteristics and shock occurrence on ICD patient outcome a multicenter report - The Bilitch Registry Group . Pacing Clin Electrophysiol. 14:1991;1881-1886.
7. Mehta D., Saksena S., Krol R. Survival of implantable cardioverter-defibrillator recipients role of left ventricular function and its relation to device use . Am Heart J. 124:1992;1608-1614.
8. Grimm W., Flores B.T., Marchlinski F.E. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation. 87:1993;1880-1888.
9. Villacastin J., Almendral J., Arenal A., et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation. 93:1996;753-762.
10. Kim S.G., Fisher J.D., Choue C.W., et al. Influence of left ventricular function on outcome of patients treated with implantable cardioverter defibrillators. Circulation. 85:1992;1304-1310.
11. ESVEM Investigators , Caruso A.C., Marcus F.I., Hahn E.A., Hartz V.L., Mason J.W. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Circulation. 96:1997;1888-1892.
12. Pacifico A., Wheelan K.R., Nasir N. Jr, et al. Long-term follow-up of implantable cardioverter-defibrillator implanted under conscious sedation in prepectoral subfascial position. Circulation. 95:1997;946-950.
13. Pacifico A., Cedillo-Salazar F.R., Nasir N. Jr, Doyle T.K., Henry P.D. Conscious sedation with combined hypnotic agents for implantation of implantable cardioverter-defibrillators. J Am Coll Cardiol. 30:1997;769-773.
14. Hook B.G., Callans D.J., Kleiman R.B., Flores B.T., Marchlinski F.E. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms rhythm diagnosis and management aided by stored electrogram analysis . Circulation. 87:1993;1897-1906.
15. Nisam S., Breithardt G. Mortality trials with implantable defibrillators. Am J Cardiol. 79:1997;468-471.
16. Kalbfleisch J.D., Prentice R.L. The Statistical Analysis of Failure Time Data. 1980;Wiley, New York.
17. Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators . Comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
18. Multicenter Automatic Defibrillator Implantation Trial Investigators , Moss A.J., Hall J., Cannom D.S. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 335:1996;1933-1940.
19. Pacifico A., Johnson J., Stanton M.S., et al. Comparison of results in two implantable defibrillators. Am J Cardiol. 82:1988;875-880.
20. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. Prognostic value of baseline electrophysiologic studies: The AVID trial (abstr). Circulation 1997;96:I-334.
21. Giorgberidze I., Saksena S., Krol R.B., et al. Risk stratification and clinical outcome of minimally symptomatic patients with nonsustained ventricular tachycardia and coronary disease. Am J Cardiol. 80:(5B):1997;3F-9F.
22. Marchlinski F.E. Predicting arrhythmic death - a plea for standardized reporting techniques and data based on continuous electrocardiographic monitoring. Circulation. 96:1997;1713-1716.